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ABSTRACT 
Objective: The present study was to evaluate the oral toxicity of acute and sub acute studies of methanol leaf and bark extract of Dolichandrone atrovirens 
Methods: In acute toxicity studies of aqueous methanolic Dolichandrone atrovirens leaf extract(DALE) and Dolichandrone atrovirens bark extracts 
(DABE) (in 0.3 % sodium CMC) as a single dose (2000 mg/kg) was administered to the Swiss albino mice (20-25 g) by oral route and the animals 
were observed for mortality and any toxic symptoms up to 14 days. In sub acute toxicity studies the DALE and DABE were administered daily for 28 
days at doses ranging from 200-400 mg/kg. The animals were found in signs of toxicity, morbidity and mortality for 28 days. The animals were 
submitted to observe the serum biochemical markers and weight of the vital organs. 
Results: The results of 14 days acute toxicity studies up to a dose of 2000 mg/kg of the aqueous methanolic DABE and DALE neither produced 
mortality nor shows any symptoms of behavior or any physiological changes in body weight, food and water intake. 28 days sub acute studies 
repeated doses of oral toxicity did not show any toxic signs or any mortality when three doses 200 and 400 mg/kg of the methanolic leaf and bark 
extracts of Dolichandrone atrovirens administered. No significant changes were integrated in biochemical and hematological parameters when 
compared with the control group.  
Conclusion: From the results it is concluded that the dose at 400 mg/kg is safe for long term treatment in diabetic conditions. 




The pharmacological treatment of disease began with the use of 
herbs [1]. Worldwide the recognition of herbal medicine was 
increased. In recent years, an increasing use of herbal medicines in 
developed countries has expanded sharply [2]. The World Health 
Organization (WHO) estimates that 80% of the world's population 
used the plant-based medicines as their primary medical 
intervention [3, 4]. At the same time medicinal herbs produced some 
notable toxicity like renal and hepatic toxicity [5]. In India, the use of 
herbal medicine is the Vedic period and the popular medical plants 
which are reported in texts like Ayurveda and Sidha. Most of the new 
drugs which are approved from 1994 are based on natural products 
[6]. The use of herbal drugs for the management of certain ailments 
continues unabated in most developing communities due to easy 
access and for economic reasons [7]. In the absence of reliable liver-
protective drugs in allopathic medical practices, herbs play a role in 
the management of various liver disorders [8].  
Dolichandrone atrovirens are used in Indian traditional system to 
treat rheumatism, arthritis, diabetes, inflammation, and liver 
diseases. Diuretic and antispasmodic effects are reported for the use 
of Dolichandrone atrovirens seeds. The powder is applied externally 
to treat swelling and decoction of the bark is provided for stomach 
pain [9, 10] and also has the antioxidant and antidiabetic activity 
[11, 12]. There are a lot of herbals was used to treat diabetics, but 
the toxicity has not been properly addressed. The present study was 
conducted the toxicity of the aqueous methanol leaf and bark extract 
of Dolichandrone atrovirensactive. Hence, the leaf and bark extract 
was submitted to acute and sub acute toxicity studies to further 
confirm these activities using animals.  
MATERIALS AND METHODS 
Plant material  
The leaves and bark of Dolichandrone atrovirens were collected from 
Chitheri hills, Salem in the month of November 2009. The plant was 
then authenticated and a voucher specimen is related for further 
reference. 
Preparation of extract 
The shade dried coarse powders of the plant material (1.5 kg) were 
extracted with 80 %v/v aqueous methanol by maceration at room 
temperature for 72 h and the extract was filtered, concentrated to 
dryness in a rotavapor under reduced pressure and controlled 
temperature (40-50 °C). The extractive values and nature of the leaf 
and bark extracts of Dolichandrone atrovirens were administered 
orally to the experiments.  
Experimental animals  
Healthy Swiss albino mice and wistar rats were fed with standard 
animal pellet diet and water ad libitum. The experiment protocols 
received clearance from the Institutional Animal Ethical Committee 
(IAEC) and CPCSEA, Chennai, India. 
Acute toxicity  
The overnight fasted Swiss albino mice (20-25 g) were weighed and 
administered the methanolic leaf and bark extracts of Dolichandrone 
atrovirens (in 0.3 % sodium CMC) as a single dose (2000 mg/kg) by 
oral route and the animals were observed for toxic symptoms 
continuously for first 4 hours.  
Number of survivors was noted after 24 hours and the 
observation made daily for a period of 14 days. Toxic symptoms 
for which the animals were found in 72 hrs included behavioral 
changes, convulsions, locomotion and mortality. Cage side 
observations included changes in skin, fur, eyes, mucous 
membranes, somato-motor activity, respiratory, autonomic, 
central nervous systems, and behavior pattern. Special attention 
was addressed to observations of tremors, lethargy, sleep 
convulsions, salivation, diarrhea, and coma. Body weight, water 
and food intake were accounted for. 
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Subacute toxicity  
Five groups of adult male albino rats (150-160g) were used for sub 
acute toxicity. Group 1 (control treated with 0.3% sodium CMC (2 
ml/kg, p. o), Group 2 (methanolic leaf extract of D. atrovirens 200 
mg/kg, p. o), Group 3-Methanolic leaf extract of D. atrovirens 400 
mg/kg, p. o), Group 4 (methanolic bark extract of D. atrovirens 200 
mg/kg, p. o) and Group 5 (methanolic bark extract of D. atrovirens 
400 mg/kg, p. o) 
After completion of the study period, blood samples were harvested 
from overnight fasted animals after 24 h of the last dose of plant extracts 
and analyzed the hematological parameter. In addition, blood glucose, 
total cholesterol, serum glutamate oxaloacetate transaminase (SGOT), 
serum glutamate pyruvate transaminase (SGPT), gamma glutamate 
transpeptidase (GGTP), Alkaline phosphatase (ALP), BUN, total bilirubin, 
urea, total protein, albumin and creatinine were also estimated. The 
urine analysis was performed to investigate any abnormalities in the 
excretion pattern after the exposure with a test drug for 28 days. The 
urine was harvested from each animal at the end of the study early in the 
morning and it was analyzed for the detection of abnormal constitutions.  
RESULTS 
Acute toxicity  
Methanolic lead and bark extracts of D. atrovirens did not cause any 
mortality in mice up to 2000 mg/kg. None of the doses tested 
produced any apparent gross effect on general motor activity, fecal 
output, muscular weakness, feeding behaviour etc. during the period 
of observation. This indicated that the extracts were considered to 
be safe at the tested dose level.  
Sub-acute toxicity  
During the experimental period of 28 days, the increase in body 
weight in all test groups was not significantly different from control 
group. At the end of the study period, no statistically significant 
differences were seen in the mean haemoglobin content. WBC, RBC, 
hematocrit, clotting time and differential cell counts of all test 
groups when compared to control group no and mean biochemical 
parameters. The consequence of urine analysis does not show any 
abnormalities in the excretion pattern. 
DISCUSSION 
The safe dose range of drug can be determining by the LD 50
 
 values 
through acute toxicity studies [13, 14]. In the present study, animals 
treated with DALE and DABE did not show any toxic symptoms or 
mortality when dosed up to 2000 mg/kg body weight by oral route. 
This indicates that the extracts are found to be harmless at the 
tested dose level. Sub-acute toxicity study gives valuable 
information on the cumulative toxicity of a substance on target 
organs or physiological and metabolic effects of the compound at a 
low dose on prolonged exposure. A wide variety of adverse effects 
can be detected with sub acute toxicity studies. The result from such 
studies can give information, which will aid in selecting dose level. 
The long term safety level of a compound can be expected from 
acute or shorter than sub acute studies [15, 16]. 
Table 1: Effect of DALE and DABE on body weight of the extract treated animals 
Design of treatment Day 0 Day 7 Day 14 Day 21 Day 28 
Control 150.5±3.61 154.7±3.72 160.7±2.71 167.5±4.03* 175.3±3.28* 
DALE 200 151.4±3.54 155.5±2.41 162.8±2.31* 166.7±2.38** 172.4±1.23*** 
DALE 400 153.7±1.69 156±2.26 160.8±2.41 167.7±3.11*** 176.6±3.24*** 
DABE 200 154.5±1.69 158.17±1.83* 163.3±1.55*** 168.3±1.41*** 173.5±2.12*** 
DABE 400 153±1.74 157.7±1.76 162.3±2.44** 169.1±1.92*** 174±2.86*** 
N=6; Values were expressed as mean±SEM; Data were analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test; NS-Not 
significant when compared to control; *P<0.05, **P<0.01, ***P<0.001 when compared to Day ‘0’. 
 
Table 2: Effect of DALE and DABE on hematological parameters of the extract treated animals 
Parameters  Control DALE 200 DALE 400 DABE 200 DABE 400 
HGB (g/dL) 15.32±0.15 14.98±0.52 15.9±0.26 15.93±0.17 14.2±1.13 
RBC (M/μL) 5.05±0.05 5.53±0.31 5.35±0.13 5.4±0.09 5.26±0.39 
HCT (%) 46.17±0.65 41.95±2.6 47.83±1.01 48±0.68 41.17±3.53 
PLT (K/μL) 485±16.68 558±53.34 575±36.58 613±28.59 637±64.40 
WBC (K/μL) 7.13±0.65 8.68±0.94 7.85±0.66 9.83±0.40 9.76±2.65 
LYM (%) 82.3±1.75 84.5±1.08 84.5±2.01 82.6±1.43 72.8±6.75 
MID (%) 12.18 1.11 11.15±0.64 10.83±1.39 12±0.93 15.27±2.39 
GRANULO (%) 5.52±0.76 4.32±0.65 4.63±0.86 5.41±0.87 7.42±0.24 
N=6; Values were expressed as mean±SEM; Data were analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test; NS-Not 
significant when compared to control. 
 
Table 3: Effect of DALE and DABE on serum hepatic and renal parameters of extract treated animals 
Parameters  Control DALE 200 DALE 400 DABE 200 DABE 400 
SGOT (IU/l) 188±4.15 194.5±4.96 198.33±5.14 201±6.34 193.16±6.06 
SGPT (IU/l) 80.17±2.65 90.73±3.68 94.33±2.45 93.7±4.0 94.83±4.64 
ALP (IU/l) 191±6.66 214.67±9.6 219±6.52 221.67±6.37 223.3±11.24 
GGTP (IU/l) 43.83±2.21 45±2.32 45.5±2.52 44±1.84 48.67±0.76 
Total Bilirubin (mg/dL) 0.6±0.05 0.65±0.07 0.633±0.07 0.583±0.06 0.633±0.07 
Glucose (mg/dL) 84.9±0.95 85.97±1.10 85.63±0.85 83.03±0.76 85.9±1.09 
Total cholesterol (mg/dL) 102±8.30 102.8±6.74 111.5±10.57 114.3±6.28 100.9±7.29 
Urea (mg/dL) 57.5±3.14 53.3±2.33 62.67±3.13 58±5.02 62.5±5.49 
BUN (mg/dL) 26.78±1.48 24.88±1.09 29.23±1.48 27.1±2.33 29.17±2.57 
Creatinine (mg/dL) 0.75±0.02 0.733±0.03 0.817±0.03 0.8±0.02 0.817±0.03 
Total Protein (g/dL) 6.92±0.09 7.1±0.06 7.13±0.04 6.9±0.05 6.83±0.14 
Albumin (g/dL) 4.067±0.06 4.183±0.07 4.217±0.07 4.083±0.07 4.00±0.11 
N=6; Values were expressed as mean±SEM; Data were analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test; NS-Not 
significant when compared to control. 
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Table 4: Urine analysis of DALE and DABE treated animals 
Parameters  Control DALE 200 DALE 400 DABE 200 DABE 400 
Appearance Straw Yellow Straw Yellow Straw Yellow Straw Yellow Straw Yellow 
Specific gravity 1.02±0.003 1.03±0.0034 1.04±0.003 1.02±0.004 1.02±0.002 
pH 6.42±0.03 6.43±0.02 6.47±0.02 6.47±0.02 6.43±0.02 
Glucose NIL NIL NIL NIL NIL 
Proteins NIL NIL NIL NIL NIL 
Ketone bodies NIL NIL NIL NIL NIL 
Blood cells NIL NIL NIL NIL NIL 
N=6; Values were expressed as mean±SEM; Data were analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test; NS-Not 
significant when compared to control. 
 
Table 5: Effect of DALE and DABE on weight of vital organs of extract treated animals 
Name of organs Weight of organs (g/100g of body weight) 
Normal  DALE 200 DALE 400 DABE 200 DABE 400 
Liver 4.34±0.09 4.86±0.09 4.72±0.13 4.62±0.2 4.68±0.18 
Kidneys 1.03±0.05 1.18±0.04 1.10±0.04 1.16±0.04 1.21±0.05 
Heart 0.63±0.01 0.64±0.02 0.62±0.03 0.59±0.01 0.63±0.01 
Lungs 1.04±0.01 1.17±0.04 1.17±0.07 1.06±0.03 1.01±0.06 
Spleen 0.34±0.02 0.39±0.01 0.41±0.02 0.38±0.02 0.39±0.02 
N=6; Values were expressed as mean±SEM; Data were analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test; NS-Not 
significant when compared to control. 
 
End of the study period, no statically significant differences were 
seen in the mean Hb content, WBC, RBC and differential cell counts 
of all test groups when compared with control group. Further there 
were no changes observed in the serum biochemical markers viz., 
SGOT, SGPT, ALP, Total protein, Total cholesterol, Total bilirubin 
level and clotting time in all test groups when compared to control 
group. The consequence of urine analysis does not show any 
abnormalities in excretion pattern.  
Both the leaves and bark extract of Dolichandrone atrovirens are free 
from adverse effects on hepatic and renal systems and their 
function. There was not any mortality for administered leaves and 
bark extract of Dolichandrone atrovirens at a very high dose. The 
weight of the principal organs also showed that, there were no 
statistically significant differences observed in all test groups when 
compared to control group.  
CONCLUSION  
The results of the present study concluded that aqueous methanol 
leaf and bark extract of Dolichandrone atrovirens was non toxic and 
no marked changes in hematological, biochemical parameters. 
However, further studies have to be order to evaluate long term 
toxicities. 
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